NO123472B - - Google Patents
Download PDFInfo
- Publication number
- NO123472B NO123472B NO170794A NO17079467A NO123472B NO 123472 B NO123472 B NO 123472B NO 170794 A NO170794 A NO 170794A NO 17079467 A NO17079467 A NO 17079467A NO 123472 B NO123472 B NO 123472B
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- solution
- polymer
- contrast agent
- groups
- Prior art date
Links
- 239000002872 contrast media Substances 0.000 claims description 33
- 229920000642 polymer Polymers 0.000 claims description 30
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- CRVYPNHLIAWRNV-UHFFFAOYSA-N 2,4,6-triiodobenzoic acid Chemical group OC(=O)C1=C(I)C=C(I)C=C1I CRVYPNHLIAWRNV-UHFFFAOYSA-N 0.000 claims description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000000047 product Substances 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 16
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 159000000000 sodium salts Chemical class 0.000 description 12
- 210000003462 vein Anatomy 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 239000011630 iodine Substances 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- -1 3>5-diacylamino-2 Chemical class 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 210000001635 urinary tract Anatomy 0.000 description 5
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000792859 Enema Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000007920 enema Substances 0.000 description 3
- 229940095399 enema Drugs 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 210000000244 kidney pelvis Anatomy 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- ZMZGFLUUZLELNE-UHFFFAOYSA-N 2,3,5-triiodobenzoic acid Chemical group OC(=O)C1=CC(I)=CC(I)=C1I ZMZGFLUUZLELNE-UHFFFAOYSA-N 0.000 description 2
- JBJLEUTWAFDYOV-UHFFFAOYSA-N 3-amino-5-(aminomethyl)-2,4,6-triiodobenzoic acid Chemical group NCC=1C(=C(C(=O)O)C(=C(C1I)N)I)I JBJLEUTWAFDYOV-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical group OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- GOQCZMZLABPEME-UHFFFAOYSA-N 3,5-diamino-2,4,6-triiodobenzoic acid Chemical group NC1=C(I)C(N)=C(I)C(C(O)=O)=C1I GOQCZMZLABPEME-UHFFFAOYSA-N 0.000 description 1
- BWKWJRRDHNBJTI-UHFFFAOYSA-N 3-amino-5-carbamoyl-2,4,6-triiodobenzoic acid Chemical group NC(=O)C1=C(I)C(N)=C(I)C(C(O)=O)=C1I BWKWJRRDHNBJTI-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000013189 cholangiography Methods 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical group OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- 150000003944 halohydrins Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000002924 oxiranes Chemical group 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/026—Wholly aromatic polyamines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polyamides (AREA)
- Epoxy Resins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE16513/66D SE348110B (en, 2012) | 1966-12-02 | 1966-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO123472B true NO123472B (en, 2012) | 1971-11-22 |
Family
ID=20302365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO170794A NO123472B (en, 2012) | 1966-12-02 | 1967-12-01 |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT281278B (en, 2012) |
| CH (1) | CH475766A (en, 2012) |
| DE (1) | DE1617743C3 (en, 2012) |
| DK (1) | DK117377B (en, 2012) |
| FI (1) | FI47523C (en, 2012) |
| GB (1) | GB1204862A (en, 2012) |
| NO (1) | NO123472B (en, 2012) |
| SE (1) | SE348110B (en, 2012) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356277A (en) | 1977-03-08 | 1982-10-26 | Ppg Industries, Inc. | Reaction products of a polyglycidyl ether of a polyphenol and an amino acid and aqueous solubilized products therefrom |
| US4299747A (en) | 1977-03-08 | 1981-11-10 | Ppg Industries, Inc. | Reaction products of a polyglycidyl ether of a polyphenol and an amino acid and aqueous solubilized products therefrom |
| GB0725070D0 (en) * | 2007-12-21 | 2008-01-30 | Iopharma Technologies Ab | Product |
| WO2018100540A1 (en) * | 2016-11-30 | 2018-06-07 | Texas Children's Hospital | Hydrophilic fluorinated molecules for liposomal 19f mri probes with unique mr signatures |
-
1966
- 1966-12-02 SE SE16513/66D patent/SE348110B/xx unknown
-
1967
- 1967-11-29 DK DK597267AA patent/DK117377B/da unknown
- 1967-12-01 DE DE1617743A patent/DE1617743C3/de not_active Expired
- 1967-12-01 AT AT1089167A patent/AT281278B/de active
- 1967-12-01 NO NO170794A patent/NO123472B/no unknown
- 1967-12-01 GB GB54788/67A patent/GB1204862A/en not_active Expired
- 1967-12-01 CH CH1693567A patent/CH475766A/fr not_active IP Right Cessation
- 1967-12-01 FI FI673234A patent/FI47523C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| DE1617743C3 (de) | 1973-11-08 |
| CH475766A (fr) | 1969-07-31 |
| DE1617743A1 (de) | 1972-03-16 |
| FI47523C (fi) | 1974-01-10 |
| AT281278B (de) | 1970-05-11 |
| DK117377B (da) | 1970-04-20 |
| FI47523B (en, 2012) | 1973-10-01 |
| DE1617743B2 (de) | 1973-04-12 |
| SE348110B (en, 2012) | 1972-08-28 |
| GB1204862A (en) | 1970-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3852341A (en) | Novel iodine containing polymers useful as x-ray contrast agents | |
| DK167998B1 (da) | Diagnostisk middel indeholdende en ikke-radioaktiv metalspecies kemisk bundet til makromolekylaere forbindelser samt anvendelse af disse forbindelser med den bundne metalspecies til fremstilling af et middel til brug ved nmr- og ultralydsdiagnostik | |
| US5866100A (en) | Compositions for imaging of the gastrointestinal tract | |
| AU735018B2 (en) | MRI contrast media recognizing microenvironmental changes | |
| JP2022126716A (ja) | 新規な架橋アルギン酸 | |
| JP7704952B2 (ja) | 新規な架橋アルギン酸 | |
| CN114805644B (zh) | 一种不透射聚合物及其制备方法和应用 | |
| Rezaei et al. | pH-triggered prodrug micelles for cisplatin delivery: preparation and in vitro/vivo evaluation | |
| US5126440A (en) | Iodinated polymers with dextran skeleton, processes for their preparation and their uses as contrast products | |
| NO123472B (en, 2012) | ||
| JPH08509721A (ja) | ヨウ素化ポリマービーズを含有するポリマーｘ線造影組成物 | |
| AU608816B2 (en) | Iodinated polymers | |
| DE2346774A1 (de) | Roentgenkontrastmittel | |
| WO2000016811A2 (en) | Mri contrast agent | |
| NO127279B (en, 2012) | ||
| Okamura et al. | Synthesis and properties of radiopaque polymer hydrogels: polyion complexes of copolymers of acrylamide derivatives having triiodophenyl and carboxyl groups and p-styrene sulfonate and polyallylamine | |
| AT285039B (de) | Röntgenkontrastmittel | |
| NO127280B (en, 2012) | ||
| NO170937B (no) | Fremgangsmaate for fremstilling av 2-arylpropionsyre-magnesiumhalogenidkomplekser | |
| DE1809014C3 (de) | Röntgenkontrastmittel | |
| Björk et al. | Improved Polymeric Contrast Agents for Roentgenologic Examination of the Gastrointestinal Tract: I. Preliminary Report on the Chemistry of the Polymers | |
| WO2024170683A1 (en) | In situ gelling liquid embolic formulations and related methods | |
| US3632737A (en) | Method for the x-ray visualization of body cavities and a preparation for carrying out the method | |
| AT290722B (de) | Röntgenkontrastmittel | |
| Chiellini et al. | Biodegradable synthetic and semisynthetic polymers |